Sahajanand Medical Technologies' initial public offering (IPO) was 82% subscribed by 5 PM on the second day of bidding. Investors placed bids for 80,37,775 shares out of the 97,50,482 shares offered, indicating strong interest in the company's share sale.
- The IPO is a complete offer for sale (OFS) worth ₹475 crore.
- The price band is set between ₹327 and ₹344 per share.
- The minimum application lot size is 43 shares.
- Subscription by category: Qualified Institutional Buyers (QIB) 1.12 times, Retail Individual Investors (RII) 0.82 times, Non-Institutional Investors (NII) 0.51 times.
- The company raised ₹140 crore from anchor investors before the IPO.
What is Sahajanand Medical Technologies?
Sahajanand Medical Technologies (SMT) is a company specializing in high-risk Class III and Class C/D cardiovascular medical devices. Founded in 2001, SMT develops and manufactures advanced medical devices used in vascular and structural heart interventions.
The company's product portfolio includes coronary stents, PTCA balloon catheters, drug-coated balloons, transcatheter aortic valve implantation (TAVI) systems, occluders, renal stents, peripheral drug-coated balloons, and other traded products.
How does Sahajanand Medical Technologies operate?
SMT combines in-house research and development with integrated manufacturing and proprietary branding. The company generates clinical evidence to support its products and uses a multi-channel distribution system to market them.
In the fiscal year 2026, SMT marketed its products in 77 countries, demonstrating a wide global reach.
Where are Sahajanand Medical Technologies' facilities located?
The company manufactures its products in Hyderabad and Sachin SEZ in Surat, India, as well as in Nonthaburi, Thailand. It operates research and development centers in India and Thailand, supported by a team of 156 professionals, including four consultants.
What are the details of the IPO?
The IPO is a book-building issue with a price band of ₹327 to ₹344 per share. The minimum application size is one lot, which consists of 43 shares. Before the IPO, SMT raised ₹140 crore from anchor investors by allotting 40.71 lakh equity shares at the upper price band of ₹344 per share.
The shares will be listed on both the National Stock Exchange and the Bombay Stock Exchange.
How will the funds raised from the IPO be used?
The money raised from the IPO will be used to support the company's growth and expansion plans, including research and development, manufacturing capacity enhancement, and working capital requirements.
Frequently Asked Questions
Q: What is the subscription status of Sahajanand Medical Technologies' IPO on Day 2?
A: By 5 PM on Day 2, the IPO was 82% subscribed with bids for 80,37,775 shares against 97,50,482 shares offered.
Q: What is the price band for the IPO?
A: The price band is set between ₹327 and ₹344 per share.
Q: What categories of investors participated in the IPO?
A: The Qualified Institutional Buyers (QIB) category was subscribed 1.12 times, Retail Individual Investors (RII) 0.82 times, and Non-Institutional Investors (NII) 0.51 times.
Q: Where will Sahajanand Medical Technologies' shares be listed?
A: The shares will be listed on the National Stock Exchange and the Bombay Stock Exchange.
